Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290498
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2006-02-10
Brief Title:
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkins Lymphomas in Patients 60 Years Old or Younger
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-10
First Submit QC Date:
February 10 2006
Study First Post Date:
2006-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-06-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-18
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL